Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 The share buyback resolved on 24 June 2022 by the Managing Board of Siemens Healthineers AG (hereinafter also referred to as "Company") will commence on 29 June 2022. In the time  [ … ]

Disclosure pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 The share buyback resolved on 24 June 2022 by the Managing Board of Siemens Healthineers AG (hereinafter also referred to as "Company") will commence on 29 June 2022. In the time  [ … ]

Q1 results significantly better than market expectations; Outlook for FY2021 raised Based on our broad portfolio and strong global presence we were able to meet pandemic-related demands. At the same time, our assumption for a further normalization of demand for standard procedures to pre-pandemic levels has been re-affirmed. The combination of the [ … ]

Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) and Art. 2 para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback - 8th Interim Reporting In the time period from and including 18 January 2021 until and including 22 January 2021, a number of 131,964 shares of Siemens Healthineers AG w [ … ]

Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of Delegated Regulation (EU) No. 2016/1052 The share buyback resolved on 29 September 2020 by the Managing Board of Siemens Healthineers AG (hereinafter also referred to as "Company") will commence on 7 October 2020. In the time period until 5 Fe [ … ]

Erlangen, September 2, 2020Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014 Siemens Healthineers determines the placement price for the new shares from the capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAP [ … ]

Erlangen, September 2, 2020Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014 Siemens Healthineers launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN OR INTO THE UNITED STA [ … ]

Siemens Healthineers AG (Frankfurt: SHL) ("Siemens Healthineers") today entered into an agreement with Varian Medical Systems, Inc. (NYSE: VAR) ("Varian"), a global leader in the field of cancer care, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of Vari [ … ]